Back to search

Article

Are TERT promoter mutations a poor prognostic factor in anaplastic thyroid carcinoma?

2023-07-18

Abstract excerpt

<title>Abstract</title> <p>Purpose Telomerase reverse transcriptase (<italic>TERT</italic>) promoter mutations are a poor prognostic factor in differentiated thyroid carcinoma (DTC). However, their prognostic value in anaplastic thyroid carcinoma (ATC) is unclear. Therefore, we investigated whether <italic>TERT</italic> promoter mutations also act as an independent poor prognostic factor in ATC. Methods We revi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ef08036-d8a3-5eb9-b44b-5f5f7e27347b
DOI
10.21203/rs.3.rs-3138194/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Are TERT promoter mutations a poor prognostic factor in anaplastic thyroid carcinoma?DOI 10.21203/rs.3.rs-3138194/v1
Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.Semantic proximity
Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis.Semantic proximity
BRAF and TERT promoter mutations: clinical application in thyroid cancer.Semantic proximity
Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter MutationsSemantic proximity
The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer.Semantic proximity
TERT promoter mutations in thyroid cancer.Semantic proximity
Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.Semantic proximity
Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review.Semantic proximity
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients.Semantic proximity
TERT promoter mutations and long-term survival in patients with thyroid cancer.Semantic proximity
Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.Semantic proximity
TERT promoter-mutated thyroid carcinomas: prognostic and histologic insights according to the WHO 2022 classification.Semantic proximity
Select a neighboring publication to make it the new centre.